Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

(2020) Milagritos D Tapia et al.   LANCET INFECTIOUS DISEASES

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

(2020) Ramon Roozendaal et al.   npj Vaccines

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

(2020) Andrew J Pollard et al.   LANCET INFECTIOUS DISEASES

Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania

(2019) Zacchaeus Anywaine et al.   JOURNAL OF INFECTIOUS DISEASES

Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya

(2019) Gaudensia Mutua et al.   JOURNAL OF INFECTIOUS DISEASES

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

(2019) Yolanda Guerra Mendoza et al.   Human Vaccines & Immunotherapeutics

Ebola Vaccine Trials: Progress in Vaccine Safety and Immunogenicity

(2019) Keesha M. Matz et al.   Expert Review of Vaccines

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

(2017) Ana Maria Henao-Restrepo et al.   LANCET

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants

(2017) Carly M. Bliss et al.   MOLECULAR THERAPY

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants

(2016) Muhammed O Afolabi et al.   MOLECULAR THERAPY

Anemia, Micronutrient Deficiencies, and Malaria in Children and Women in Sierra Leone Prior to the Ebola Outbreak - Findings of a Cross-Sectional Study

(2016) James P Wirth et al.   PLoS One

Ebola Virus Disease among Children in West Africa

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans

(2015) Jarad M. Schiffer et al.   VACCINE

Biochemical and Hematologic Parameters for Children in the Middle Belt of Ghana

(2014) David K. Dosoo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Safety of 13-valent pneumococcal conjugate vaccine in infants and children: Meta-analysis of 13 clinical trials in 9 countries

(2013) Allison Thompson et al.   VACCINE

Safety and immunogenicity of 10-valent pneumococcal nontypeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Nigerian children

(2013) Olumuyiwa O Odusanya et al.   Human Vaccines & Immunotherapeutics

Vaccine administration and the development of immune thrombocytopenic purpura in children

(2013) Valerio Cecinati et al.   Human Vaccines & Immunotherapeutics

Thrombocytopenic Purpura after Measles-Mumps-Rubella Vaccination: A Systematic Review of the Literature and Guidance for Management

(2010) Elpis Mantadakis et al.   JOURNAL OF PEDIATRICS